Intercept Pharmaceuticals, Inc.
TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE

Last updated:

Abstract:

The present application relates to methods of treating or preventing an intestinal inflammatory disease or condition (e.g., intestinal ischemia reperfusion injury) in a subject in need thereof, comprising administering a therapeutically effective amount of a compound of the application.

Status:
Application
Type:

Utility

Filling date:

3 Feb 2020

Issue date:

31 Mar 2022